NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 283 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,274,000 | -67.0% | 104,873 | -7.2% | 0.03% | -65.3% |
| Q4 2021 | $3,856,000 | -11.7% | 113,007 | +24.8% | 0.08% | -33.0% |
| Q3 2021 | $4,367,000 | +33.1% | 90,536 | +24.7% | 0.11% | +7.7% |
| Q2 2021 | $3,281,000 | +8.3% | 72,632 | +15.6% | 0.10% | -8.0% |
| Q1 2021 | $3,030,000 | +68.9% | 62,816 | +88.5% | 0.11% | +36.1% |
| Q4 2020 | $1,794,000 | +180.3% | 33,319 | +92.2% | 0.08% | +130.6% |
| Q3 2020 | $640,000 | +64.5% | 17,337 | +38.1% | 0.04% | -44.6% |
| Q2 2020 | $389,000 | +177.9% | 12,551 | +146.9% | 0.06% | -14.5% |
| Q1 2020 | $140,000 | +45.8% | 5,083 | +54.5% | 0.08% | +280.0% |
| Q4 2019 | $96,000 | – | 3,291 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |